THCB

Categories

Category: Health Tech

WeChat to Many, WeDoctor to Some

By KIM BELLARD

You’ve probably heard about TikTok, especially lately.  President Trump wanted a ban on it, and seems to have endorsed a deal for a U.S.-based version of it.  The hundred million U.S. users, and probably their parents, are undoubtedly watching the sequence of events with mixed amusement and concern. 

But you may have paid less attention to what’s been going on with WeChat, another China-based app.  WeChat was part of the original proposed ban, which a federal judge blocked this weekend, hours before it was due to go into effect (the Commerce Department plans to appeal).  The ban is on “transactions,” which, in WeChat’s case, covers a lot of ground. 

TikTok was overlooked by authority figures for a long time because it was mostly used by young people and mostly for what seemed, to them, to be trivial purposes.  Not so with WeChat; it is deeply engrained in users’ lives, including for their health.  

WeChat is owned by Tencent Holdings, one of China’s internet giants.  It has been described as a “Swiss Army knife” app, able to do many tasks – not just messaging and social networking, but also games, shopping, and payments.  You can order food or book travel.  For many users it is a primary source of news, which is part of the problem. 

Continue reading…

THCB Gang Episode 25 9/17

Joining Zoya Khan (@zoyak1594) on Episode 25 of “The THCB Gang” were regulars patient advocate Grace Cordovano (@GraceCordovano), writer Kim Bellard (@kimbbellard), policy & tech expert Vince Kuraitis (@VinceKuraitis), data privacy expert Deven McGraw (@healthprivacy), and guest Rosemarie Day, Founder & CEO of Day Health Strategies (@Rosemarie_Day1). Rosemary’s book “Marching Towards Coverage” is out now. The conversation revolved around new health technology policies, Medicaid Expansion programs, the 2020 election, and the steps to get to universal health coverage. Oh, and you can take Rosemary’s quiz about what type of a health activist you are!

If you’d rather listen to the episode, the audio is preserved as a weekly podcast available on our iTunes & Spotify channels — Zoya Khan

Kids & Mental Health: Brightline Aims to “Grow Up” Pediatric Behavioral Health Care with Tech

By JESSICA DAMASSA

Despite the fact that kids make up 20% of our national patient population and that their parents are likely just the tech-savvy market of health consumers that most digital health companies are targeting with their own virtual care solutions, very little has been done to use technology to ‘transform’ the way that they take care of their kids. One of the founders hoping to push this market into a growth spurt is Naomi Allen, co-founder & CEO of pediatric behavioral health company Brightline.

From seed to Series A in just 8 months ($25M total funding), Brightline is already looking to scale out its full-stack clinical model to help tackle the behavioral health issues that are often under-diagnosed and under-treated in kids. Naomi says that 75% of all severe mental illness manifests before age 14, but that only 1 in 5 kids will ever even get a behavioral health diagnosis. And more shocking? Of those that are diagnosed, only 1 in 5 of those kids will ever even receive any care.

The supply-and-demand equation is off — stymied not only by a clinician shortage, but by literally poor reimbursement from health plans concerned about the lack of quality metrics, measurements, and processes in pediatric behavioral health despite the prevalence of those kinds of quality guidelines around adult mental health care.

So, how is Brightline going to fix this? Technology, clinicians, coaches. A full-stack clinical model with a “scaffolding” of support for parents built around it using telehealth, digital tools, and, for those health plans, metrics. Tune in to find out more about their business model, what Brightline’s kids are saying, and how you can find their services yourself if you think your child might need help.

Continue reading…

Healthcare Can Learn From Chess

By KIM BELLARD

Oh, gosh, two of my favorite things are in the news together: Twitch and chess. 

Just kidding.  I barely know what Twitch is, and the last time I played chess was, well, not in this century (and, even then, not well).  But I’m not kidding about their convergence.  Chess has become a big hit on Twitch, especially in these COVID times. 

I figure, if two such seemingly divergent things are meshing, there must be some lessons there, even for healthcare. 

For those of you over, say, fifty, Twitch is an online service that facilitates livestreaming, particularly of gaming.  That is, people watch other people playing games, such Fortnite or League of Legends. 

E-sports, as this is known, have become a big thing; colleges are even giving out scholarships for e-sports.   Major news outlets, such as The New York Times and The Washington Post, reported on Twitch re-signing video game star Tyler Blevins, a.k.a “Ninja,” much as they might have reported an NFL team signing a star player. 

As I write, 2.7 million people are livingstreaming on Twitch.  Its all-time concurrent viewers peak is just over 6 million.  There were 1.6 billion hours watched in August, with over 11 billion year-to-date.  It draws more viewers than network television hits. There are 93,000 live channels at this moment. 

Continue reading…

THCB Gang Episode 24!

Episode 24 of “The THCB Gang” was live-streamed on Thursday, September 10th! Watch it below!

Joining Matthew Holt (@boltyboy) were some of our regulars: WTF Health Host Jessica DaMassa (@jessdamassa), patient & entrepreneur Robin Farmanfarmaian (@Robinff3), writer Kim Bellard (@kimbbellard), policy & tech expert Vince Kuraitis (@VinceKuraitis), and guest Mike Magee, a medical historian & health economist (@drmikemagee). The conversation was incredibly wide-ranging and one of the best we’ve had in a while–not the least because Mike Magee gave us a great base with how our non -health system somehow did actually act as a cohesive force in society before tech, then COVID19 broke it up!

If you’d rather listen to the episode, the audio is preserved as a weekly podcast available on our iTunes & Spotify channels — Zoya Khan

Don’t want my age revealed…

By LISA SUENNEN & MATTHEW HOLT

Yesterday it was Fortune’s 40 under 40, and a lot of great people, most of whom I thought were much older or at least seem to have been around a while, got listed in the health care section–including Andre Blackman, Ambar Bhattacharyya & Julia Cheek. Lisa Suennen (@venturevalkyrie) and I got into a Twitter exchange about whether we were eligible for the under 40 category or for that matter the category above that. The answer was, amazingly, “no”. Somehow she came out with the line that “we are old”. Knowing her love for 80s pop, I reminded her that this was the inverse of the first line of the Pat Benatar classic “Love is a Battlefield.” Somehow this ended up in us tweeting a new set of lyrics for that song to each other all day. Of course I feel compelled to share them with you. I encourage you to play the video below and sing along!

We are old
Wheelchair to wheelchair we sit….
No Promise ring, yes Depends
Don’t want my age revealed

Before Long
They will all sing our swan song
Scans of our hearts show something wrong
Both of us slowing..
Don’t want my age revealed

Ads begging me to Ro
Then making me pay
Why do my knees hurt so bad?
It would help me to know
Should I stand a different way?
My hip hurts too, I might add

Continue reading…

Big Health’s CEO: Working With Big Healthcare (CVS) & Big Pharma (as a DTx) on Mental Health

By JESSICA DaMASSA, WTF HEALTH

Big Health bills itself as a “complete 24-hour solution for mental health,” offering Sleepio to those who have trouble sleeping and Daylight to those who suffer from worry and anxiety during the day. Fresh off a $39M Series B in June 2020 (total $54.3M) — and having just landed Daylight onto CVS Health’s digital health formulary to join Sleepio there as a “point solution” payors can easily integrate into their benefits offerings — co-founder & CEO Peter Hames stops by for an ENORMOUS conversation about the ‘state-of-play’ for digital mental health companies like his own. Has CVS Health’s digital formulary made it any easier to contract with employers and get the attention of health consumers? And, what of the attention being paid to Big Health itself? As we hit “peak platformization” in digital health, is the company a prime acquisition target? (Note: Omada Health’s CEO Sean Duffy is a friend and investor and we get a good laugh around the 15-minute mark when we fact-check some rumors… ) Finally, another “insight highlight” worth mentioning: some candid conversation on what’s happening in digital therapeutics (DTx) as Peter is the Chair of the category’s industry org, the Digital Therapeutics Alliance. Does Big Pharma still have an appetite for DTx despite some rough news about partnerships with startups in recent months? You’ll want to tune in around 17:30 for more on that too.

THCB Gang Episode 23 8/27

Episode 23 of “The THCB Gang” was live-streamed on Thursday, August 27th! Watch it below!

Matthew Holt (@boltyboy) was joined by some of our regulars: health futurist Ian Morrison (@seccurve), WTF Health Host Jessica DaMassa (@jessdamassa), health care consultant Daniel O’Neill (@dp_oneill). The conversation revolved around how providers should reshape some of their practices amid the pandemic, what the large Teladoc-Livongo merger brings to the marketplace, and how there are still lots of potential ways start-ups can fit their models into care practices in the industry.

If you’d rather listen to the episode, the audio is preserved as a weekly podcast available on our iTunes & Spotify channels — Zoya Khan

The Bayer Deal: One Drop’s CEO on New $98M & How Data Science Will Fix Chronic Condition Care

By JESSICA DaMASSA, WTF HEALTH

One Drop just landed a $98.7M deal with Bayer — and we got the details from CEO Jeff Dachis. The timing of this deal is nothing short of impeccable: less than a year after the life sciences giant led One Drop’s Series B with a $40M investment, and amidst a veritable funding frenzy aimed at growing digital health companies focused on chronic condition management. So, how is One Drop planning to use this investment (part Series C/part development fees) to expand their data science platform known for diabetes and hypertension into some of Bayer’s biggest areas of focus — cardiology, oncology, and women’s health? And how does this even-closer relationship with such a consumer health brand help One Drop further evolve the retail side of its go-to-market strategy? Don’t forget — One Drop is sold direct-to-consumer via CVS, Walmart, and Amazon in addition to the more traditional routes via employers and payers. It’s a full breakdown of the deal and a walk through the key points of differentiation Jeff sees as integral to shaping One Drop’s move for greater global market share.

THCB Gang Episode 22, 8/20

Episode 22 of “The THCB Gang” was live-streamed on Thursday, August 20th! Watch it below.

Joining Matthew Holt (@boltyboy) today are some of our regulars: writer Kim Bellard (@kimbbellard), patient safety expert Michael Millenson (MLMillenson), MD & hospital system exec Rajesh Aggarwal (@docaggarwal), data privacy expert Deven McGraw (@healthprivacy), and Casey Quinlan (@MightyCasey). The conversation revolved around the responsibilities of the CDC & HHS, why the data hasn’t been shared properly around COVID19 transmission, and why payers & providers are cautiously innovating health care.

If you’d rather listen to the episode, the audio is preserved as a weekly podcast available on our iTunes & Spotify channels — Zoya Khan

assetto corsa mods